Clinical Efficacy of Medicinal Plants Formulations for the Prevention of Androgenetic Alopecia in Korean Individuals
Article Sidebar
Main Article Content
Abstract
Androgenetic alopecia (AGA) is the most prevalent form of nonscarring alopecia, characterized by a distinct pattern of gradual hair loss. Despite its non-lethal nature, AGA can exert a profound psychosocial impact, particularly on women and younger men, affecting their quality of life. Standard therapeutic approaches for AGA commonly involve the use of finasteride and minoxidil; however, these treatments are often associated with adverse side effects, particularly with prolonged use. In this study, we present the successful management of AGA in a cohort of Korean individuals, comprising both male and female subjects (totaling 52 participants, with 12 exclusions). Significant reductions in the affected AGA area were observed across the cohort, yielding highly satisfactory outcomes. These findings suggest that the treatment modality employed in this study offers a promising alternative for AGA management in the population, demonstrating efficacy irrespective of gender.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Paik JH, Yoon JB, Sim WY, Kim BS, Kim NI. The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol. 2001;145(1):95-99. doi:10.1046/j.1365-2133.2001.04289.x.
Dawber RPR. Aetiology and pathophysiology of hair loss. Dermatology. 1987;175(Suppl 1):23-28. doi:10.1159/000248896.
Rinaldi F, Marzani B, Pinto D, Sorbellini E. Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata. J Dermatolog Treat. 2019;30(6):588-593. doi:10.1080/09546634.2018.1544405.
Marahatta S, Agrawal S, Adhikari BR, Burkhart CG. Psychological impact of alopecia areata. Dermatol Res Pract. 2020;2020:8879343. doi:10.1155/2020/8879343.
Devkota HP, Paudel KR, Khanal S, Baral A, Panth N, Adhikari-Devkota A, Jha NK, Das N, Singh SK, Chellappan DK, Dua K, Hansbro PM. Stinging nettle (Urtica dioica L.): nutritional composition, bioactive compounds, and food functional properties. Molecules. 2022;27(16):521. doi:10.3390/molecules27165219.
Li Y, Sheng Y, Liu J, Xu G, Yu W, Cui Q, Lu X, Du P, An L. Hair-growth promoting effect and anti-inflammatory mechanism of Ginkgo biloba polysaccharides. Carbohydr Polym. 2022;278:118811. doi:10.1016/j.carbpol.2021.118811.
Zhang H, Shi Q, Nan W, Wang Y, Wang S, Yang F, Li G. Ginkgolide B and bilobalide promote the growth and increase β-catenin expression in hair follicle dermal papilla cells of American minks. Biofactors. 2019;45(6):950-958. doi:10.1002/biof.1562.
Roh SS, Kim CD, Lee MH, Hwang SL, Rang MJ, Yoon YK. The hair growth promoting effect of Sophora flavescens extract and its molecular regulation. J Dermatol Sci. 2002;30(1):43-49. doi:10.1016/s0923-1811(02)00060-9.
Takahashi T, Ishino A, Arai T, Hamada C, Nakazawa Y, Iwabuchi T, Tajima M. Improvement of androgenetic alopecia with topical Sophora flavescens Aiton extract, and identification of the two active compounds in the extract that stimulate proli-feration of human hair keratinocytes. Clin Exp Dermatol. 2016;41(3):302-307. doi:10.1111/ced.12753.
Im J, Hyun J, Kim SW, Bhang SH. Enhancing the angiogenic and proliferative capacity of dermal fibroblasts with mulberry (Morus alba L) root extract. Tissue Eng Regen Med. 2022;19(1):49-57. doi:10.1007/s13770-021-00404-6.
Hyun J, Im J, Kim SW, Kim HY, Seo I, Bhang SH. Morus alba root extract induces the anagen phase in the human hair follicle dermal papilla cells. Pharmaceutics. 2021;13(8):1155. doi:10.3390/pharmaceutics13081155.
Filaire E, Dreux A, Boutot C, Ranouille E, Berthon JY. Characteristics of healthy and androgenetic alopecia scalp microbiome: Effect of Lindera strychnifolia roots extract as a natural solution for its modulation. Int J Cosmet Sci. 2020;42(6):615-621. doi:10.1111/ics.12657.
Soe ZC, Ei ZZ, Visuttijai K, Chanvorachote P. Potential natural products regulation of molecular signaling pathway in dermal papilla stem cells. Molecules. 2023;28(14):5517. doi:10.3390/molecules28145517.
Hoffmann R. TrichoScan: a novel tool for the analysis of hair growth in vivo. J Invest Dermatol Symp Proc. 2003;8(1):109-115. doi:10.1046/j.1523-1747.2003.12183.x.
Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci. 1951;53(3):708-728. doi:10.1111/j.1749-6632.1951.tb31971.x.
Birch MP, Lalla SC, Messenger AG. Female pattern hair loss. Clin Exp Dermatol. 2002;27(5):383-388. doi:10.1046/j.1365-2230.2002.01085.x.
Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977;97(3):247-254. doi:10.1111/j.1365-2133.1977.tb15179.x.
Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: efficacy, side effects, com-pliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20(12):3759-3781. doi:10.1111/jocd.14537.
Park S, Kaushik N, Lee G, Sohn Y, Hong H, Shrestha KK, An RB, Park YK, Chang I, Kim JH. A platform for determining medicinal plants with targeted 17β-hydroxysteroid dehydrogenase modulation for possible hair loss prevention. Cosmetics. 2024;11(2):32. doi:10.3390/cosmetics11020032.